Related references
Note: Only part of the references are listed.Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies
Leila T. Tchelebi et al.
JNCI CANCER SPECTRUM (2021)
Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015
Ashish A. Deshmukh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure
Mailys de Meric de Bellefon et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: Pooled results from the KEYNOTE-028 and KEYNOTE-158 studies.
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2020)
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
Sheela Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation
Allison E. Garda et al.
RADIOTHERAPY AND ONCOLOGY (2020)
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer
Sebastian Mondaca et al.
CLINICAL COLORECTAL CANCER (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Alice Bernard-Tessier et al.
CLINICAL CANCER RESEARCH (2019)
Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience
J. A. W. Hagemans et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort
Christopher M. Jones et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Anal Carcinoma, Version 2.2018
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim et al.
LANCET ONCOLOGY (2018)
Management of Stage I Squamous Cell Carcinoma of the Anal Canal
Christy Y. Chai et al.
JAMA SURGERY (2018)
Brachytherapy boost after chemoradiation in anal cancer: a systematic review
Rezarta Frakulli et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2018)
Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy
Alex K. Bryant et al.
JAMA ONCOLOGY (2018)
Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer
Karyn A. Goodman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205)
Madhur K. Garg et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
Robert Glynne-Jones et al.
LANCET ONCOLOGY (2017)
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Van K. Morris et al.
LANCET ONCOLOGY (2017)
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
Van Morris et al.
MOLECULAR CANCER RESEARCH (2017)
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients
Francesco Sclafani et al.
ONCOLOGIST (2017)
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma Implications for Immunotherapy
Elizabeth L. Yanik et al.
JAMA ONCOLOGY (2017)
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
P. A. Ott et al.
ANNALS OF ONCOLOGY (2017)
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
Devarati Mitra et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
R. Muirhead et al.
CLINICAL ONCOLOGY (2017)
Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results
Thomas Gryc et al.
BRACHYTHERAPY (2016)
Long-term anorectal, urinary and sexual dysfunction causing distress after radiotherapy for anal cancer: a Danish multicentre cross-sectional questionnaire study
K. G. Sunesen et al.
COLORECTAL DISEASE (2015)
High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis
Ivona Baricevic et al.
EUROPEAN JOURNAL OF CANCER (2015)
Late effects and quality of life after chemo-radiation for the treatment of anal cancer
Gillian Knowles et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2015)
A tumor control probability model for anal squamous cell carcinoma
Rebecca Muirhead et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer
Kristina Mirabeau-Beale et al.
PRACTICAL RADIATION ONCOLOGY (2015)
Salvage Surgery for Residual Primary and Locally Recurrent Anal Squamous Cell Carcinoma After Chemoradiotherapy in HIV-positive Individuals
Laila Cunin et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
D. Meulendijks et al.
BRITISH JOURNAL OF CANCER (2014)
Anal Cancer: Developing an Intensity-modulated Radiotherapy Solution for ACT2 Fractionation
R. Muirhead et al.
CLINICAL ONCOLOGY (2014)
INTESTINAL STEM CELL ACTIVATION IN CROHN'S DISEASE: THE ROLE OF QUIESCENT STEM CELLS.
E. Messaris et al.
DISEASES OF THE COLON & RECTUM (2014)
Carboplatin and Paclitaxel Treatment Is Effective in Advanced Anal Cancer
Richard Kim et al.
ONCOLOGY (2014)
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
Cathy Eng et al.
ONCOTARGET (2014)
Inguinal Lymph Node Recurrence in the Untreated Groin of Patients with Anal Carcinoma
Sanne E. Blinde et al.
DISEASES OF THE COLON & RECTUM (2014)
Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial
Leonard L. Gunderson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Salvage abdominoperineal resection for anal cancer following chemoradiation: A proposed scoring system for predicting postoperative survival
Jose Humberto S. Correa et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial
Roger D. James et al.
LANCET ONCOLOGY (2013)
Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort
Anne Gry Bentzen et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Abdominoperineal Resection for Squamous Cell Anal Carcinoma: Survival and Risk Factors for Recurrence
Jeremie H. Lefevre et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Teresa M. Darragh et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer
Michael Ng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
DOSE-PAINTED INTENSITY-MODULATED RADIATION THERAPY FOR ANAL CANCER: A MULTI-INSTITUTIONAL REPORT OF ACUTE TOXICITY AND RESPONSE TO THERAPY
Lisa A. Kachnic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
Didier Peiffert et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Outcomes of Salvage Surgery for Epidermoid Carcinoma of the Anus Following Failed Combined Modality Treatment (vol 201, pg 624, 2011)
Gareth Eeson et al.
AMERICAN JOURNAL OF SURGERY (2011)
HIGH-DOSE SPLIT-COURSE RADIATION THERAPY FOR ANAL CANCER: OUTCOME ANALYSIS REGARDING THE BOOST STRATEGY (CORS-03 STUDY)
Jean-Michel Hannoun-Levi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment
Gareth Eeson et al.
AMERICAN JOURNAL OF SURGERY (2011)
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
J. Northover et al.
BRITISH JOURNAL OF CANCER (2010)
Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11
Edgar Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
ELECTIVE CLINICAL TARGET VOLUMES FOR CONFORMAL THERAPY IN ANORECTAL CANCER: A RADIATION THERAPY ONCOLOGY GROUP CONSENSUS PANEL CONTOURING ATLAS
Robert J. Myerson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
OUTCOMES OF CHEMORADIOTHERAPY WITH 5-FLUOROURACIL AND MITOMYCIN C FOR ANAL CANCER IN IMMUNOCOMPETENT VERSUS IMMUNODEFICIENT PATIENTS
Yuji Seo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
US Intergroup Anal Carcinoma Trial: Tumor Diameter Predicts for Colostomy
Jaffer A. Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Abdominoperineal resection for anal cancer
P. Mariani et al.
DISEASES OF THE COLON & RECTUM (2008)
Extra - A multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer
Rob Glynne-Jones et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal - A randomized controlled trial
Jaffer A. Ajani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Induction therapy for poor-prognosis anal canal carcinoma: A phase II study of the cancer and leukemia group B (CALGB 9281)
Neal J. Meropol et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Outcomes of salvage surgery for squamous cell carcinoma of the anal canal
Dan E. Schiller et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer
Prajnan Das et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities
Scott Edelman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer
AG Renehan et al.
BRITISH JOURNAL OF SURGERY (2005)
Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy
RF Stadler et al.
DISEASES OF THE COLON & RECTUM (2004)
Quality of life after non-surgical treatment of anal carcinoma: A case control study of long-term survivors
CR Jephcott et al.
CLINICAL ONCOLOGY (2004)
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy
RP Akbari et al.
DISEASES OF THE COLON & RECTUM (2004)
Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal
E Deniaud-Alexandre et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Cisplatin-based combined modality therapy for anal carcinoma - A wider therapeutic index
A Hung et al.
CANCER (2003)
The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy
DC Weber et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Outcome analysis of HIV-positive patients with anal squamous cell carcinoma
RJ Place et al.
DISEASES OF THE COLON & RECTUM (2001)
Share Paper
